Home » Topics » Regulatory

Regulatory
RSS

U.K. introduction for Nasonex

May 29, 1997

Promising data from pivotal trials of Actiq reported at ASCO

May 26, 1997

Mylan receives FDA approval of generic captopril/hydrochlorothiazide

May 23, 1997

Mylan receives FDA approval for generic etodolac

May 22, 1997

Merck updates development of higher dose Zocor

May 21, 1997

SmithKline Beecham's Famvir receives U.K. approval for new indication

May 21, 1997

Gensia receives ANDA approval for etoposide injection

May 21, 1997

Roche seeks FDA approval for new formulation of saquinavir

May 14, 1997

Bristol-Myers Squibb launches Vagistat-1 as OTC in the U.S.

May 13, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...